Switch to
More onapp

How to use scorecard? Learn more

Aurobindo Pharma Ltd

AUROPHARMA
Health CarePharmaceuticals
MidcapWith a market cap of ₹86,879 cr, stock is ranked 123
Moderate RiskStock is 2.10x as volatile as Nifty
1,495.8529.90 (+2.04%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
MidcapWith a market cap of ₹86,879 cr, stock is ranked 123
Moderate RiskStock is 2.10x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
24.67
PB RatioPB Ratio
2.91
Dividend YieldDiv. Yield
0.30%
Sector PESector PE
52.29
Sector PBSector PB
6.68
Sector Div YldSctr Div Yld
0.47%

Forecast & RatingsDetailed Forecast 

69%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).

Brands

Aurobindo Pharma

Pharmaceutical company

Brands

Aurobindo Pharma

Pharmaceutical company

Financial TrendFinancial statements 

202120222023202428.4023.8925.1529.565.332.651.933.17
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.35%

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnOct 7, 2024

Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Sale or disposal-XBRL 
Announced OnOct 5, 2024

AUROBINDO PHARMA LIMITED has informed the Exchange regarding Sale or disposal of unit(s)/division(s)/subsidiary | Download

AUROBINDO PHARMA LIMITED has informed the Exchange regarding Sale or disposal of unit(s)/division(s)/subsidiary | Download

Cash Dividend 
Ex. DateFeb 20, 2024

Interim 2 • Div/Share: ₹ 1.5

See all events